Log in

OTCMKTS:AMFEAmfil Technologies Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume643,100 shs
Average Volume578,338 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Amfil Technologies Inc., through its subsidiary, Interloc-Kings Inc., provides landscape construction and snow removal services in Canada. It supplies and installs a range of interlocking stones for driveways, as well as offers fencing design services, and residential or commercial snow clearing services. The company, through its subsidiary, Snakes & Lagers Inc., operates a tabletop gaming bar and cafe located in Toronto, Ontario. In addition, Amfil Technologies Inc., through its other subsidiary, provides ozone based antimicrobial systems, which eliminate of bacteria, mold, and other pathogens from cannabis cultivation facilities, reducing or eliminating the need for harsh chemicals and pesticides during the cultivation process. The antimicrobial systems used to treat hydroponic reservoirs, plants, and surrounding surface areas during various stages of the grow cycle. Amfil Technologies, Inc. was founded in 2009 and is based in Markham, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Pollution & Treatment Controls
Current SymbolOTCMKTS:AMFE



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive AMFE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMFE and its competitors with MarketBeat's FREE daily newsletter.

Amfil Technologies (OTCMKTS:AMFE) Frequently Asked Questions

Has Amfil Technologies been receiving favorable news coverage?

News headlines about AMFE stock have trended very negative on Monday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Amfil Technologies earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Amfil Technologies.

Who are some of Amfil Technologies' key competitors?

What other stocks do shareholders of Amfil Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amfil Technologies investors own include General Cannabis (CANN), United Cannabis (CNAB), InMed Pharmaceuticals (IMLFF), mCig (MCIG), Canopy Growth (CGC), Cannabis Science (CBIS), Cannabis Sativa (CBDS), Catabasis Pharmaceuticals (CATB), Baozun (BZUN) and Weed (BUDZ).

Who are Amfil Technologies' key executives?

Amfil Technologies' management team includes the following people:
  • Mr. Roger Francis Mortimer, CEO, Pres & Director (Age 34)
  • Mr. Larry Leverton, VP, Sec. & Director (Age 80)

What is Amfil Technologies' stock symbol?

Amfil Technologies trades on the OTCMKTS under the ticker symbol "AMFE."

How do I buy shares of Amfil Technologies?

Shares of AMFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amfil Technologies' stock price today?

One share of AMFE stock can currently be purchased for approximately $0.01.

What is Amfil Technologies' official website?

The official website for Amfil Technologies is www.amfiltech.com.

How can I contact Amfil Technologies?

Amfil Technologies' mailing address is 805 Fiero Ln Ste F, SAN LUIS OBISPO, CA 93401-8911, United States. The company can be reached via phone at +1-805-2752433.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.